Tag Archives: TG Therapeutics

TG Therapeutics (TGTX) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Edward White maintained a Buy rating on TG Therapeutics (TGTX – Research Report) today and set a price target of $20. The company’s shares closed on Friday at $5.54, close to its 52-week low of $4.20. White

H.C. Wainwright Sticks to Its Buy Rating for TG Therapeutics (TGTX)

H.C. Wainwright analyst Edward White maintained a Buy rating on TG Therapeutics (NASDAQ: TGTX) today and set a price target of $21. The company’s shares closed yesterday at $4.93, close to its 52-week low of $4.20. White wrote: “We use

TG Therapeutics (TGTX) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Edward White maintained a Buy rating on TG Therapeutics (NASDAQ: TGTX) today and set a price target of $38. The company’s shares opened today at $11.95. White commented: “Our price target of $38 is based on the

A Director at TG Therapeutics (NASDAQ: TGTX) is Selling Shares

Today, a Director at TG Therapeutics (NASDAQ: TGTX), William James Kennedy, sold shares of TGTX for $337.2K. Following William James Kennedy’s last TGTX Sell transaction on April 12, 2017, the stock climbed by 3.7%. See today’s analyst top recommended stocks

Raymond James Maintains Their Buy Rating on TG Therapeutics

Raymond James analyst Reni Benjamin maintained a Buy rating on TG Therapeutics (NASDAQ: TGTX) yesterday. The company’s shares closed yesterday at $14.35. Benjamin observed: “We are maintaining our Strong Buy rating for TG Therapeutics. Today, at the American Academy of

TG Therapeutics Receives a Buy from Raymond James

Raymond James analyst Reni Benjamin reiterated a Buy rating on TG Therapeutics (NASDAQ: TGTX) today. The company’s shares opened today at $14.20. Benjamin noted: “We are reiterating our Strong Buy rating on TG Therapeutics. At the 2018 American Association of